E.G7-OVA In Vitro High Content Screening (HCS) Assay

This assay is to provide E.G7-OVA-based In Vitro High Content Screening (HCS) Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.

E.G7-OVA

Mouse

E.G7-OVA [derivative of EL4] T lymphoblasts are T lymphoblasts derived in 1988 from the C57BL/6 (H-2 b) mouse lymphoma cell line EL4. E.G7-OVA [derivative of EL4] is a model system for studying major histocompatibility complex (MHC) class I restricted responses of cytotoxic T lymphocytes in mice.

Lymphoma

Oncology

In Vitro High Content Screening (HCS) Assay

HCS is one of the latest techniques used in cancer drug discovery programs. Unlike traditional HTS platforms, HCS provides more visual information about the experiment being conducted. HCS is a very powerful tool for multivariate and quantitative data analysis. Cellbased HCS systems have also gained much attention in biological research and cancer drug discovery programs.

High-throughput Screening, High Content Screening and Reporter Gene Assays